RT Journal Article
SR Electronic
T1 COVID-19 experience: first Italian survey on healthcare staff members from a Mother-Child Research Hospital using combined molecular and rapid immunoassays test
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.19.20071563
DO 10.1101/2020.04.19.20071563
A1 Comar, Manola
A1 Brumat, Marco
A1 Concas, Maria Pina
A1 Argentini, Giorgia
A1 Bianco, Annamonica
A1 Bicego, Livia
A1 Bottega, Roberta
A1 Carli, Petra
A1 Cassone, Andrea
A1 Catamo, Eulalia
A1 Cocca, Massimiliano
A1 Del Pin, Massimo
A1 Di Stazio, Mariateresa
A1 Feresin, Agnese
A1 Bianca, Martina La
A1 Morassut, Sara
A1 Morgan, Anna
A1 Pelliccione, Giulia
A1 Petix, Vincenzo
A1 Ragusa, Giulia
A1 Robino, Antonietta
A1 Russian, Stefano
A1 Spedicati, Beatrice
A1 Suergiu, Sarah
A1 Urriza, Marianela
A1 Vascotto, Fulvia
A1 Toscani, Paola
A1 Girotto, Giorgia
A1 Gasparini, Paolo
YR 2020
UL http://medrxiv.org/content/early/2020/04/22/2020.04.19.20071563.abstract
AB The fast spread of the novel coronavirus (SARS-CoV-2) has become a global threat hitting the worldwide fragile health care system. In Italy, there is a continued COVID-19 growth of cases and deaths that requires control measures for the correct management of the epidemiological emergency. To contribute to increasing the overall knowledge of COVID-19, systematic tests in the general population are required.Here, we describe the first Italian survey performed in 727 employees belonging to a Mother-Child Research hospital tested for both viral (nasopharyngeal and oropharyngeal swabs) and antibody presence. Individuals were divided into three risk categories (high, medium and low) according to their job activity. Only one subject was positive at the swab test while 17.2% of the cohort was positive for the presence of antibodies. Results highlighted that the presence of Positive antibodies is significantly associated with high and medium risk exposure occupation (p-value=0.026) as well as cold and conjunctivitis symptoms (p-value=0.016 and 0.042 respectively). Moreover, among healthcare professionals, the category of medical doctors showed a significant association with the presence of antibodies against SARS-CoV-2 (p-value=0.0127). Finally, we detected a rapid decrease in antibody intensity between two assessments performed within a very short period (p-value=0.009). Overall, the present study increases our knowledge of the epidemiological data of COVID-19 infection in Italy, suggesting a high prevalence of immune individuals (i.e. at least among at-risk categories) and the efficacy of the combined diagnostic protocol to monitor the possible outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Mother-Child Research Hospital IRCCS-Burlo Garofolo and by a kind donation from Eurospital (www.eurospital.com). We thank Veronika Collovati for assistance in data collection and consistency checks.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset completely anonymized will be made available by the Chief Medical Officer team.